Millennials And Gen Xers Are Unaware Of Nonmelanoma, Found In A New Study New research suggests four in five millennials and Gen Xers are mindful about the sun with mixed results in use of sunscreen. Zenger · May 16, 2023
Looking Into DermTech's Return On Capital Employed Benzinga Pro data, DermTech (NASDAQ:DMTK) reported Q1 sales of $3.72 million. Earnings fell to a loss of $30.11 million, resulting in a 15.56% decrease from last quarter. Benzinga · May 13, 2022
DermTech: Q1 Earnings Insights DermTech (NASDAQ:DMTK) reported its Q1 earnings results on Tuesday, May 3, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings DermTech missed estimated earnings by 13.48%, reporting an EPS of $-1.01 versus an estimate of $-0.89. Benzinga · May 3, 2022
DermTech's Earnings Outlook DermTech (NASDAQ:DMTK) is set to give its latest quarterly earnings report on Tuesday, 2022-05-03. Here's what investors need to know before the announcement. Analysts estimate that DermTech will report an earnings per share (EPS) of $-0.89. Benzinga · May 2, 2022
DermTech: Q4 Earnings Insights DermTech (NASDAQ:DMTK) reported its Q4 earnings results on Tuesday, March 1, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings DermTech missed estimated earnings by 20.55%, reporting an EPS of $-0.88 versus an estimate of $-0.73. Benzinga · Mar 1, 2022
Earnings Outlook For DermTech DermTech (NASDAQ:DMTK) is set to give its latest quarterly earnings report on Tuesday, 2022-03-01. Here's what investors need to know before the announcement. Analysts estimate that DermTech will report an earnings per share (EPS) of $-0.73. Benzinga · Feb 28, 2022